About Memory Clinic Ochanomizu
Clinical Trials at Memory Clinic Ochanomizu
During the past decade, Memory Clinic Ochanomizu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Memory Clinic Ochanomizu
According to Clinical.Site data, the most researched conditions in "Memory Clinic Ochanomizu" are
"Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Memory Clinic Ochanomizu" in a lesser frequency.
Clinical Trials Intervention Types at Memory Clinic Ochanomizu
Most popular intervention types in "Memory Clinic Ochanomizu" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "LY3372689" (1 trials), "Remternetug (IV)" (1 trials) and "Remternetug (SC)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Memory Clinic Ochanomizu
The vast majority of trials in "Memory Clinic Ochanomizu" are
2 trials for "All" genders.
Clinical Trials Status at Memory Clinic Ochanomizu
Currently, there are NaN active trials in "Memory Clinic Ochanomizu".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Memory Clinic Ochanomizu,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Memory Clinic Ochanomizu, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".